The authors reported significant modifications in biomarkers related to astrogliosis and amyloidogenesis, finding new evidence that PEA can restore behavioral deficits and impaired molecular pathways similar to early traits of AD by activating PPAR-α [104]. The gene discussed is PPARA; the disease is Alzheimer disease.